Literature DB >> 30967423

Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.

Waed Abdel Khalek1,2, Chloé Rafael1,2,3,4,5, Irmine Loisel-Ferreira1,2, Ilektra Kouranti1,2, Eric Clauser1,2, Juliette Hadchouel6,2,3,4, Xavier Jeunemaitre6,2,7.   

Abstract

BACKGROUND: Mutations in four genes, WNK lysine deficient protein kinase 1 and 4 (WNK1 and WNK4), kelch like family member 3 (KLHL3), or Cullin 3 (CUL3), can result in familial hyperkalemic hypertension (FHHt), a rare Mendelian form of human arterial hypertension. Although all mutations result in an increased abundance of WNK1 or WNK4, all FHHt-causing CUL3 mutations, resulting in the skipping of exon 9, lead to a more severe phenotype.
METHODS: We created and compared two mouse models, one expressing the mutant Cul3 protein ubiquitously (pgk-Cul3∆9) and the other specifically in vascular smooth muscle cells (SM22-Cul3∆9). We conducted pharmacologic investigations on isolated aortas and generated stable and inducible HEK293 cell lines that overexpress the wild-type Cul3 or mutant Cul3 (Cul3∆9) protein.
RESULTS: As expected, pgk-Cul3∆9 mice showed marked hypertension with significant hyperkalemia, hyperchloremia and low renin. BP increased significantly in SM22-Cul3∆9 mice, independent of any measurable effect on renal transport. Only pgk-Cul3∆9 mice displayed increased expression of the sodium chloride cotransporter and phosphorylation by the WNK-SPAK kinases. Both models showed altered reactivity of isolated aortas to phenylephrine and acetylcholine, as well as marked acute BP sensitivity to the calcium channel blocker amlodipine. Aortas from SM22-Cul3∆9 mice showed increased expression of RhoA, a key molecule involved in regulation of vascular tone, compared with aortas from control mice. We also observed increased RhoA abundance and t 1/2 in Cul3∆9-expressing cells, caused by decreased ubiquitination.
CONCLUSIONS: Mutations in Cul3 cause severe hypertension by affecting both renal and vascular function, the latter being associated with activation of RhoA.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Hemodynamics and Vascular Regulation; RhoA; Ubiquitination; WNK kinases; distal tubule; hypertension

Mesh:

Substances:

Year:  2019        PMID: 30967423      PMCID: PMC6493989          DOI: 10.1681/ASN.2017121307

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

1.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

Review 2.  Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.

Authors:  Ryan J Cornelius; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

Review 3.  The WNK signaling pathway and salt-sensitive hypertension.

Authors:  Taisuke Furusho; Shinichi Uchida; Eisei Sohara
Journal:  Hypertens Res       Date:  2020-04-14       Impact factor: 3.872

Review 4.  Cullin-3: Renal and Vascular Mechanisms Regulating Blood Pressure.

Authors:  Jing Wu; James A McCormick; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2020-08-27       Impact factor: 5.369

Review 5.  WNK4 kinase: from structure to physiology.

Authors:  Adrián Rafael Murillo-de-Ozores; Alejandro Rodríguez-Gama; Héctor Carbajal-Contreras; Gerardo Gamba; María Castañeda-Bueno
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-25

6.  Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.

Authors:  Yujiro Maeoka; Mohammed Z Ferdaus; Ryan J Cornelius; Avika Sharma; Xiao-Tong Su; Lauren N Miller; Joshua A Robertson; Susan B Gurley; Chao-Ling Yang; David H Ellison; James A McCormick
Journal:  J Am Soc Nephrol       Date:  2022-01-21       Impact factor: 14.978

Review 7.  Role of the Cation-Chloride-Cotransporters in Cardiovascular Disease.

Authors:  Nur Farah Meor Azlan; Jinwei Zhang
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

Review 8.  Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Authors:  Shi Fang; M Christine Livergood; Pablo Nakagawa; Jing Wu; Curt D Sigmund
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 23.213

Review 9.  Role of the Ubiquitin Proteasome System in the Regulation of Blood Pressure: A Review.

Authors:  Osamu Yamazaki; Daigoro Hirohama; Kenichi Ishizawa; Shigeru Shibata
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

Review 10.  The Molecular Genetics of Gordon Syndrome.

Authors:  Holly Mabillard; John A Sayer
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.